Guidance for Sagent Pharmaceuticals, Inc. (SGNT)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2016 | N/A | N/A | $325.00M – 365.00M | $378.10M | = Maintained | Details |
| 2015 | N/A | N/A | $325.00M – 375.00M | $343.40M | = Maintained | Details |
| 2015 | N/A | N/A | $325.00M – 375.00M | $345.80M | = Maintained | Details |
| 2014 | N/A | N/A | $250.00M – 290.00M | $282.50M | = Maintained | Details |
| 2014 | N/A | N/A | $270.00M – 290.00M | $279.07M | = Maintained | Details |
| 2014 | N/A | N/A | $275.00M – 285.00M | $287.80M | = Maintained | Details |
| 2013 | N/A | N/A | $220.00M – 250.00M | $238.13M | = Maintained | Details |
| 2012 | N/A | N/A | $220.00M – 250.00M | $234.10M | = Maintained | Details |
| 2012 | N/A | N/A | $180.00M – 200.00M | $187.39M | = Maintained | Details |
| 2012 | N/A | N/A | $180.00M – 200.00M | $221.08M |  Lowered |
Details |
